Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STR001 in Sudden Sensorineural Hearing Loss
2017-000242-22Phase 3Completed
- Sponsor
- Strekin AG
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute sensorineural hearing loss comparing STR001 (pioglitazone) with Placebo (2 arms). Started Mar 2017; status: completed.
02
Drugs
pioglitazone
03
Conditions
acute sensorineural hearing loss
Beyond the preview
Go deeper on 2017-000242-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000242-22.